266 related articles for article (PubMed ID: 32152147)
1. Serum cell-free DNA and progression of diabetic kidney disease: a prospective study.
Li X; Hu R; Luo T; Peng C; Gong L; Hu J; Yang S; Li Q
BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32152147
[TBL] [Abstract][Full Text] [Related]
2. Correlation Between Serum 25-Hydroxyvitamin D Levels in Albuminuria Progression of Diabetic Kidney Disease and Underlying Mechanisms By Bioinformatics Analysis.
Huang B; Wen W; Ye S
Front Endocrinol (Lausanne); 2022; 13():880930. PubMed ID: 35634488
[TBL] [Abstract][Full Text] [Related]
3. Serum bisphenol A and progression of type 2 diabetic nephropathy: a 6-year prospective study.
Hu J; Yang S; Wang Y; Goswami R; Peng C; Gao R; Zhou H; Zhang Y; Cheng Q; Zhen Q; Li Q
Acta Diabetol; 2015 Dec; 52(6):1135-41. PubMed ID: 26321107
[TBL] [Abstract][Full Text] [Related]
4. Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 Years in Adults With Type 1 Diabetes: The CACTI Study.
Bjornstad P; Wiromrat P; Johnson RJ; Sippl R; Cherney DZI; Wong R; Rewers MJ; Snell-Bergeon JK
Diabetes Care; 2019 Feb; 42(2):297-302. PubMed ID: 30482755
[TBL] [Abstract][Full Text] [Related]
5. Establishment and validation of the cut-off values of estimated glomerular filtration rate and urinary albumin-to-creatinine ratio for diabetic kidney disease: A multi-center, prospective cohort study.
Gao Z; Zhu Y; Sun X; Zhu H; Jiang W; Sun M; Wang J; Liu L; Zheng H; Qin Y; Zhang S; Yang Y; Xu J; Yang J; Shan C; Chang B
Front Endocrinol (Lausanne); 2022; 13():1064665. PubMed ID: 36578951
[TBL] [Abstract][Full Text] [Related]
6. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
[TBL] [Abstract][Full Text] [Related]
7. A study of the natural history of diabetic kidney disease (DKD).
Altemtam N; Russell J; El Nahas M
Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for the Development and Progression of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Advanced Diabetic Retinopathy.
Yun KJ; Kim HJ; Kim MK; Kwon HS; Baek KH; Roh YJ; Song KH
Diabetes Metab J; 2016 Dec; 40(6):473-481. PubMed ID: 27766790
[TBL] [Abstract][Full Text] [Related]
9. Serum and Urinary Progranulin in Diabetic Kidney Disease.
Nicoletto BB; Krolikowski TC; Crispim D; Canani LH
PLoS One; 2016; 11(10):e0165177. PubMed ID: 27776152
[TBL] [Abstract][Full Text] [Related]
10. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease.
Wu L; Li XQ; Chang DY; Zhang H; Li JJ; Wu SL; Zhang LX; Chen M; Zhao MH
Nephrol Dial Transplant; 2020 Feb; 35(2):291-297. PubMed ID: 30357416
[TBL] [Abstract][Full Text] [Related]
11. Circulating asprosin levels are increased in patients with type 2 diabetes and associated with early-stage diabetic kidney disease.
Zhang H; Hu W; Zhang G
Int Urol Nephrol; 2020 Aug; 52(8):1517-1522. PubMed ID: 32458209
[TBL] [Abstract][Full Text] [Related]
12. Serum myeloid-related protein 8/14 is a potential predictor of diabetic kidney disease.
Gu W; Cui J; Shi M; Zhang R; Tan D; Zhang X; Zhang H
Discov Med; 2020; 30(160):97-105. PubMed ID: 33382965
[TBL] [Abstract][Full Text] [Related]
13. Plasma angiotensin-converting enzyme 2 (ACE2) is a marker for renal outcome of diabetic kidney disease (DKD) (U-CARE study 3).
Ueno A; Onishi Y; Mise K; Yamaguchi S; Kanno A; Nojima I; Higuchi C; Uchida HA; Shikata K; Miyamoto S; Nakatsuka A; Eguchi J; Hida K; Katayama A; Watanabe M; Nakato T; Tone A; Teshigawara S; Matsuoka T; Kamei S; Murakami K; Shimizu I; Miyashita K; Ando S; Nunoue T; Wada J
BMJ Open Diabetes Res Care; 2024 May; 12(3):. PubMed ID: 38816205
[TBL] [Abstract][Full Text] [Related]
14. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
[TBL] [Abstract][Full Text] [Related]
15. Serum stromal cell-derived factor-1 levels are associated with diabetic kidney disease in type 2 diabetic patients.
Lu CF; Ma JH; Su JB; Wang XQ; Liu WS; Ge XQ
Endocr J; 2021 Sep; 68(9):1101-1107. PubMed ID: 33896872
[TBL] [Abstract][Full Text] [Related]
16. Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study.
Yamanouchi M; Furuichi K; Shimizu M; Toyama T; Yamamura Y; Oshima M; Kitajima S; Hara A; Iwata Y; Sakai N; Oba Y; Matsuoka S; Ikuma D; Mizuno H; Suwabe T; Hoshino J; Sawa N; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Makino H; Matsuo S; Ubara Y; Wada T
Nephrol Dial Transplant; 2022 Feb; 37(3):489-497. PubMed ID: 34028524
[TBL] [Abstract][Full Text] [Related]
17. Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study.
Chen S; Chen L; Jiang H
Ren Fail; 2022 Dec; 44(1):1309-1318. PubMed ID: 35938702
[TBL] [Abstract][Full Text] [Related]
18. Correlations of Serum Retinol-Binding Protein and Stromal Cell-Derived Factor-1 with Renal Function in Patients with Diabetic Kidney Disease.
Huang J; Liu J; Liu W
Clin Lab; 2024 Jan; 70(1):. PubMed ID: 38213220
[TBL] [Abstract][Full Text] [Related]
19. Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study.
Cid Ruzafa J; Paczkowski R; Boye KS; Di Tanna GL; Sheetz MJ; Donaldson R; Breyer MD; Neasham D; Voelker JR
Int J Clin Pract; 2015 Aug; 69(8):871-82. PubMed ID: 26011029
[TBL] [Abstract][Full Text] [Related]
20. Implications of increased circulating macrophage inhibitory protein-5 in patients with type 2 diabetes mellitus.
Zhao B; Zhang M; Xie J; Jiang T; Li J; Yang Z
Int Immunopharmacol; 2022 Aug; 109():108916. PubMed ID: 35679662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
